CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-06 | Rodberg James Chief Financial Officer | Sale | −594 | $7.48 | $4K | 153,846 |
| 2026-01-06 | Bauerlein Alison Chief Operating Officer | Sale | −9,647 | $7.48 | $72K | 599,983 |
| 2026-01-06 | Taylor Brenton EVP, Operations & R&D | Sale | −619 | $7.48 | $5K | 170,212 |
| 2026-01-05 | HAYDEN JEREMY B. Chief Legal Officer | Sale 10b5-1 | −9,385 | $7.82 | $73K | 247,205 |
| 2026-01-05 | Badawi David Chief Technology Officer | Sale | −3,051 | $7.82 | $24K | 1,920,804 |
| 2026-01-05 | Rodberg James Chief Financial Officer | Sale | −4,405 | $7.82 | $34K | 154,440 |
| 2026-01-05 | Bauerlein Alison Chief Operating Officer | Sale | −10,896 | $7.82 | $85K | 609,630 |
| 2026-01-02 | Badawi Paul President and CEO | Sale | −25,356 | $7.43 | $188K | 5,937,146 |
| 2026-01-02 | Badawi David Chief Technology Officer | Sale | −2,914 | $7.43 | $22K | 1,923,855 |
| 2025-12-26 | Badawi David Chief Technology Officer | Option exercise | +21,270 | $0.23 | $5K | 1,926,769 |
| 2025-12-26 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −21,270 | 21,270 | ||
| 2025-12-16 | Encrantz Staffan Director | Purchase | +13,958 | $8.31 | $116K | 1,391,922 |
| 2025-12-02 | Rodberg James Chief Financial Officer | Sale | −2,518 | $8.25 | $21K | 158,845 |
| 2025-11-25 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise 10b5-1 | +37,560 | $1.96 | $74K | 294,150 |
| 2025-11-25 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise 10b5-1 | +7,290 | $1.96 | $14K | 301,440 |
| 2025-11-25 | HAYDEN JEREMY B. Chief Legal Officer | Sale 10b5-1 | −44,850 | $8.08 | $362K | 256,590 |
| 2025-11-25 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,560 | 40,000 | ||
| 2025-11-25 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,290 | 8,000 | ||
| 2025-11-17 | Taylor Brenton EVP, Operations & R&D | Sale | −14,418 | $7.06 | $102K | 170,831 |
| 2025-11-12 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise 10b5-1 | +2,440 | $1.96 | $5K | 259,030 |
Page 3 of 7 · 126 trades